VI
BMRN icon

Vestcor Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Vestcor Inc’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$918K Hold
16,048
– – 0.02% 593
2026
Q1 		$907K Buy
+16,048
New +$936K 0.03% 531
2025
Q4 		– Sell
-3,680
Closed -$199K – 1164
2025
Q3 		$199K Hold
3,680
– – 0.01% 983
2025
Q2 		$202K Sell
3,680
-33
-0.9% -$1.94K 0.01% 967
2025
Q1 		$262K Buy
3,713
+14
+0.4% +$942 0.01% 891
2024
Q4 		$243K Hold
3,699
– – 0.01% 935
2024
Q3 		$260K Hold
3,699
– – 0.01% 903
2024
Q2 		$305K Hold
3,699
– – 0.01% 824
2024
Q1 		$323K Sell
3,699
-2,498
-40% -$224K 0.01% 802
2023
Q4 		$598K Sell
6,197
-43
-0.7% -$3.8K 0.02% 602
2023
Q3 		$552K Sell
6,240
-586
-9% -$52.1K 0.02% 594
2023
Q2 		$592K Sell
6,826
-12,011
-64% -$1.13M 0.02% 569
2023
Q1 		$1.83M Sell
18,837
-55
-0.3% -$5.7K 0.07% 302
2022
Q4 		$1.96M Buy
18,892
+14,535
+334% +$1.36M 0.07% 297
2022
Q3 		$369K Buy
4,357
+75
+2% +$6.68K 0.01% 756
2022
Q2 		$355K Buy
4,282
+1,378
+47% +$110K 0.01% 771
2022
Q1 		$224K Sell
2,904
-1,609
-36% -$135K 0.01% 903
2021
Q4 		$399K Sell
4,513
-694
-13% -$57.3K 0.01% 691
2021
Q3 		$402K Sell
5,207
-346
-6% -$27.3K 0.01% 648
2021
Q2 		$463K Buy
5,553
+3,049
+122% +$242K 0.02% 642
2021
Q1 		$189K Hold
2,504
– – 0.01% 829
2020
Q4 		$220K Hold
2,504
– – 0.01% 717
2020
Q3 		$191K Hold
2,504
– – 0.01% 671
2020
Q2 		$309K Buy
+2,504
New +$249K 0.02% 513

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vestcor Inc's BMRN Position: Q2 2026 in Review

Vestcor Inc held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 16,048 shares worth $918K. The position accounts for 0.02% of the portfolio, ranked #593.

Vestcor Inc first reported a position in BMRN in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.96M in Q4 2022. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Vestcor Inc held 16,048 shares of BioMarin Pharmaceuticals worth $918K as of Q2 2026.
  • Vestcor Inc left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
  • BioMarin Pharmaceuticals made up 0.02% of Vestcor Inc's portfolio in Q2 2026, its #593 holding.
  • Vestcor Inc first reported a position in BioMarin Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Vestcor Inc's BioMarin Pharmaceuticals position peaked at $1.96M in Q4 2022.
  • 564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.